Brainscan - Public Comps and Valuation Multiples

Brainscan Overview

About Brainscan

Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes.

Founded

HQ

Employees

n/a

Website

brainscan.ai

Sectors

Healthcare Software
Health Data & Analytics
EHR & Practice Management
HealthTech
B2B SaaS
Vertical SaaS

Financials

Last FY Revenue $0.1M

Last FY EBITDA -$1.3M

EV

$8.9M

Valuation Multiples

Multiples.vc

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Brainscan Financials

In the most recent fiscal year, Brainscan achieved revenue of $0.1M and an EBITDA of -$1.3M.

Brainscan expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Brainscan valuation multiples based on analyst estimates

Brainscan P&L

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$0.1M	XXX	XXX	XXX
Gross Profit	XXX	$42K	XXX	XXX	XXX
Gross Margin	XXX	75%	XXX	XXX	XXX
EBITDA	XXX	-$1.3M	XXX	XXX	XXX
EBITDA Margin	XXX	-2219%	XXX	XXX	XXX
EBIT	XXX	-$1.3M	XXX	XXX	XXX
EBIT Margin	XXX	-2246%	XXX	XXX	XXX
Net Profit	XXX	-$1.3M	XXX	XXX	XXX
Net Margin	XXX	-2371%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Brainscan Stock Performance

As of May 30, 2025, Brainscan's stock price is PLN 30 (or $8).

Brainscan has current market cap of PLN 36.2M (or $9.6M), and EV of PLN 33.7M (or $8.9M).

See Brainscan trading valuation data

Brainscan Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$8.9M	$9.6M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Brainscan Valuation Multiples

As of May 30, 2025, Brainscan has market cap of $9.6M and EV of $8.9M.

Brainscan's trades at 157.6x EV/Revenue multiple, and -7.1x EV/EBITDA.

Equity research analysts estimate Brainscan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Brainscan's P/E ratio is not available.

See valuation multiples for Brainscan and 12K+ public comps

Brainscan Financial Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$9.6M	XXX	$9.6M	XXX	XXX	XXX
EV (current)	$8.9M	XXX	$8.9M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	157.6x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-7.1x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-7.0x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-7.1x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-8.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Brainscan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Brainscan Margins & Growth Rates

Brainscan's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Brainscan's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Brainscan's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Brainscan and other 12K+ public comps

Brainscan Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	-2219%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	2321%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial